Stockreport

Vital Therapies: An Attractive Opportunity For An Acquirer To Get The ELAD System For Almost Free [Seeking Alpha]

VITAL THERAPIES  (VTL) 
Last vital therapies earnings: 8/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vitaltherapies.com/node/5806
PDF Summary Summary: Shares of Vital Therapies ( VTL ) are trading at a market cap of just $13M after the failed VTL-308 trial. We see value in [Read more]